Recap: PGXperts at DMEA 2025

10. April 2025 /

Events

Three exciting days full of fresh impulses, innovation, and inspiring conversations at DMEA 2025 in Berlin are behind us. As part of the joint booth organized by Bayern Innovativ, we had the opportunity to present our solutions for medication safety and personalized medication to a broad professional audience. This year’s core topics included the use of artificial intelligence in healthcare and the nationwide rollout of electronic patient records (ePA).

Our Highlights:

Keynote by Herna Munoz-Galeano

In her presentation “Paradigm Shift in Drug Therapy: Safe and Effective Through Personalized Medication,” Herna impressively demonstrated the game-changing potential of pharmacogenetics for safer and more effective treatments.

Partnerships that make an impact

Vidal MMI Germany GmbH: With the integration of data4doc discharge management into PGXperts PRiM, the e-prescription becomes a practical part of everyday clinical work.
ADVANOVA GmbH: Together, we enable drug medication safety (AMTS) checks by expanding the VMobil documentation platform with PGXperts PRiM.

…

Visit from Medical Valley

Strong networks are the foundation for sustainable innovation. We were especially pleased to welcome Marco Wendel, CEO of Medical Valley EMN e.V.. We’re proud to be part of this dynamic ecosystem and to push forward innovation in personalized medicine.

Policy Meets Practice

Bavarian Minister of Health Judith Gerlach also visited the Bayern Innovativ booth. Exchanges with political decision-makers are essential to realizing our vision:
We are convinced that, in the future, it will be unimaginable for physicians not to have access to their patients’ genetic information.

Thanks for three inspiring days!

Beyond expert discussions, DMEA was a valuable platform for personal networking – whether with clinics, partners, or policymakers. We’re proud to be advancing personalized medication with our PGXperts solutions.

A heartfelt thanks to the team at Bayern Innovativ for organizing the joint booth and to our partners ADVANOVA, VIDAL MMI, and MyCare2x. And of course, thanks to everyone who visited us and showed interest in our work.

Our conclusion: DMEA remains the leading platform for digital healthcare – and we’re already looking forward to DMEA 2026!